HITS Inc.
PrivateLast Round
Series A
Extension
Nov 13, 2025
Total Funding Raised
$13.04M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
HITS Inc. is a biotechnology company that provides an AI platform for drug discovery, integrating physics and deep learning to accelerate the identification and design of new drug compounds.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Medical AI, ML Platforms, Biotechnology
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting, Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
HITS Inc. Comparables
Compare HITS Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Iktos | 85% | |
| Aigen Sciences | 83% | |
| Optibrium | 81% | |
HITS Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Nov 13, 2025 | ||||
| Series A | Feb 14, 2022 | ||||
| Seed | Oct 1, 2020 |
HITS Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Korea Investment Partners | Series A Extension, Seed, Series A |
| Company K Partners | Series A |
| Schmidt | Seed |
| Kiwoom Investment | Series A Extension, Series A |
| Capstone Partners Korea | Series A |
| STIC Ventures | Series A Extension, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 20, 2026
Open roles increased to 48, 2.5x the trailing average.
- Nov 13, 2025
Raised $7.5M led by Kiwoom Investment and Korea Investment Partners.
HITS Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about HITS Inc.'s valuation, stock price, and market status.